blake9999
Well-Known Member
The Drug Enforcement Administration (DEA) placed a marijuana-derived drug in Schedule V of the Controlled Substances Act on Thursday.
The medication, Epidiolex, contains purified cannabidiol (CBD), a non-psychoactive ingredient in cannabis. It was approved as a treatment option for severe forms of epilepsy by the Food and Drug Administration (FDA) in June.
https://www.marijuanamoment.net/the-dea-just-placed-a-marijuana-derived-drug-in-schedule-v/
The medication, Epidiolex, contains purified cannabidiol (CBD), a non-psychoactive ingredient in cannabis. It was approved as a treatment option for severe forms of epilepsy by the Food and Drug Administration (FDA) in June.
https://www.marijuanamoment.net/the-dea-just-placed-a-marijuana-derived-drug-in-schedule-v/